{
    "2021-08-10": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Vectura auction called off after Carlyle declines to beat Philip Morris bid",
                "features": {
                    "keywords": [
                        "Vectura",
                        "auction",
                        "Carlyle",
                        "Philip Morris",
                        "bid"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "No auction for Vectura as Carlyle declares $1.3 billion takeover bid final",
                "features": {
                    "keywords": [
                        "Vectura",
                        "Carlyle",
                        "takeover",
                        "final",
                        "$1.3 billion"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "UPDATE 2-No auction for Vectura as Carlyle declares $1.3 bln takeover bid final",
                "features": {
                    "keywords": [
                        "Vectura",
                        "Carlyle",
                        "takeover",
                        "final",
                        "$1.3 bln"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Philip Morris (PM) Boosts Beyond Nicotine Options With OtiTopic",
                "features": {
                    "keywords": [
                        "Philip Morris",
                        "Beyond Nicotine",
                        "OtiTopic"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Philip Morris Pivots to a Takeover Offer in Vectura Fight",
                "features": {
                    "keywords": [
                        "Philip Morris",
                        "Takeover",
                        "Vectura"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}